We are live on ! Find out more
CRIG

Charter Research & Investment Group Portfolio holdings

AUM $150M
1-Year Est. Return 28.05%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+28.05%
3 Year Est. Return
+71.14%
5 Year Est. Return
+100.32%
10 Year Est. Return
AUM
$114M
AUM Growth
+$10.5M
Cap. Flow
+$4.8M
Cap. Flow %
4.19%
Top 10 Hldgs %
40.52%
Holding
81
New
3
Increased
20
Reduced
14
Closed
1

Sector Composition

Rank Sector Weight
1 Technology 18.2%
2 Communication Services 18%
3 Healthcare 13.51%
4 Consumer Staples 12.95%
5 Industrials 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COST icon
76
Costco
COST
$423B
$205K 0.18%
581
+18
+3% +$6.27K
VEU icon
77
Vanguard FTSE All-World ex-US ETF
VEU
$69.9B
$203K 0.18%
+3,350
New +$204K
ALE
78
DELISTED
Allete
ALE
$202K 0.18%
+3,003
New +$197K
V icon
79
Visa
V
$675B
$201K 0.18%
950
WKHS icon
80
Workhorse Group
WKHS
$34.5M
$198K 0.17%
5
CELG.RT
81
Bristol-Myers Squibb Rights
CELG.RT
$206M
-12,267
Closed -$8K

Similar funds

Charter Research & Investment Group's Q1 2021 Portfolio in Review

As of Q1 2021, Charter Research & Investment Group held 81 positions worth $114M, up 10% from $104M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Charter Research & Investment Group deployed $4.8M of net new capital in Q1 2021, opening 3 new positions and adding to 20 existing holdings. Its largest new stake was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 34,845 shares worth $3.55M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Albemarle, an estimated $732K trimmed.

  • Charter Research & Investment Group's largest Q1 2021 buy was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 34,845 shares worth $3.55M.
  • Charter Research & Investment Group added most to RTX Corp in Q1 2021, an estimated $1.47M increase.
  • Charter Research & Investment Group's biggest Q1 2021 reduction was Albemarle, cutting an estimated $732K.
  • Charter Research & Investment Group fully exited Bristol-Myers Squibb Rights in Q1 2021, selling an estimated $8K.
  • Charter Research & Investment Group's ten largest holdings make up 41% of its $114M portfolio in Q1 2021.
  • Charter Research & Investment Group opened 3 new positions and closed 1 in Q1 2021.
  • Charter Research & Investment Group's portfolio value rose 10% quarter-over-quarter to $114M.

Based on Charter Research & Investment Group's 13F filing for Q1 2021, filed 14 May 2021.